Global /South Korea /Financial Services /Financial Conglomerates /359090
chevron_leftBack
C&R Research Inc. logo

C&R Research Inc.

359090
KRX: 359090 Delayed
777KRW -0.3%
0.4981 USD
As of 7 June 2026, C&R Research Inc. has a market cap of $29.13M USD, ranking #34450 globally and #2140 in South Korea. It ranks #3615 in the Financial Services sector, and #577 in the Financial Conglomerates industry.
Global Rank
34450
Country Rank
2140
Sector Rank
3615
Industry Rank
577
Key Stats
Market Cap
$29.13MUSD
44.65B KRW
Enterprise Value
$25.92MUSD
40.44B KRW
Revenue (TTM)
$42.39MUSD
64.98B KRW
EBITDA (TTM)
$1.62MUSD
2.53B KRW
Net Income (TTM)
$1.69MUSD
2.59B KRW
EBITDA Margin
3.9%
Profit Margin
4%
PE Ratio
17.3
PS Ratio
0.7
PB Ratio
0.9
EV/EBITDA
19.9
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Financial Conglomerates
CEO
Moontae Yoon open_in_new
Employees
510
Founded
1997
Website
cnrres.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% -3.5% -4% -12% -19% -26%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
359090
(주)씨엔알리서치 Ordinary Shares
ISIN: KR7359090008
Shares Out.:
57.47M1 Shares Float: 21.047M2
TV:
SA:
YF:
GF:
BA:
MS:
777 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About C&R Research Inc.

C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company’s therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea.

Similar Companies

Industry: Financial Conglomerates (South Korea)
Name
Market Cap diff.
PE
402340
$71.41B
109.46T KRW
245K%
12.5
034730
$15.12B
23.17T KRW
52K%
183.9
004800
$2.45B
3.75T KRW
8K%
11.4
$782.69M
1.2T KRW
3K%
-
368770
$502.31M
769.95B KRW
2K%
83.2
383800
$470.5M
721.19B KRW
2K%
5.3
Industry: Financial Conglomerates (Global)
Name
Market Cap diff.
PE
INVE-A
$121.36B
1.14T SEK
416K%
5.9
ITSA3
$30.39B
157.1B BRL
104K%
9.5
$22.19B
207.94B SEK
76K%
5.2
$19.01B
598.03B TWD
65K%
12.6
HAL
$17.88B
15.4B EUR
61K%
9.6
$17.29B
1.66T INR
59K%
101.9
chevron_leftBack